Related references
Note: Only part of the references are listed.Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway
Rui Zhou et al.
FRONTIERS IN PHARMACOLOGY (2021)
Bone Aging, Cellular Senescence, and Osteoporosis
Robert J. Pignolo et al.
JBMR PLUS (2021)
Metabolic Messengers: glucagon-like peptide 1
Fiona M. Gribble et al.
NATURE METABOLISM (2021)
Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway
Shuangli Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
Effects of GLP-1 receptor analogue liraglutide and DPP-4 inhibitor vildagliptin on the bone metabolism in ApoE-/- mice
Lizhi Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Dapagliflozin Attenuates Hyperglycemia Related Osteoporosis in ZDF Rats by Alleviating Hypercalciuria
Ji-Yu Wang et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Empaglifozin mitigates NAFLD in high-fat-fed mice by alleviating insulin resistance, lipogenesis and ER stress
Tamiris Ingrid Petito-da-Silva et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Dipeptidyl peptidase-4 inhibition prevents cell death via extrinsic and intrinsic apoptotic pathways in rat pancreas with insulin resistance
Gulay Nephan et al.
CELL BIOCHEMISTRY AND FUNCTION (2018)
Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability
Xiaoyan Zhou et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway
Yan-Zhen Cheng et al.
LIFE SCIENCES (2018)
The impact of Glucagon-Like Peptide-1 on Bone Metabolism and its Possible Mechanisms
Chenhe Zhao et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Activation of the receptor for advanced glycation end products and consequences on health
Marie-Paule Wautier et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes
Thomas F. Dejgaard et al.
DIABETES OBESITY & METABOLISM (2017)
Exendin-4 promotes proliferation and differentiation of MC3T3-E1 osteoblasts by MAPKs activation
Yingyu Feng et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2016)
Glucagon-like peptide-1 attenuates advanced oxidation protein product-mediated damage in islet microvascular endothelial cells partly through the RAGE pathway
Zhen Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Inhibiting receptor for advanced glycation end product (AGE) and oxidative stress involved in the protective effect mediated by glucagon-like peptide-1 receptor on AGE induced neuronal apoptosis
Song Chen et al.
NEUROSCIENCE LETTERS (2016)
Advanced Glycation End Products, Diabetes, and Bone Strength
Masahiro Yamamoto et al.
CURRENT OSTEOPOROSIS REPORTS (2016)
GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women
Eva W. Iepsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Liraglutide, the glucagon-like peptide-1 receptor agonist, has anabolic bone effects in diabetic Goto-Kakizaki rats
Han-xiao Sun et al.
JOURNAL OF DIABETES (2015)
Diabetic Complications in Obese Type 2 Diabetic Rat Models
Yoshiaki Katsuda et al.
EXPERIMENTAL ANIMALS (2014)
Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort
Noriko Yoshimura et al.
Modern Rheumatology (2014)
Insulin increases glomerular filtration barrier permeability through dimerization of protein kinase G type Iα subunits
Agnieszka Piwkowska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes
Ju-Young Kim et al.
LIFE SCIENCES (2013)
β1- and αv-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments
Herbert B. Schiller et al.
NATURE CELL BIOLOGY (2013)
Signal Transduction in Receptor for Advanced Glycation End Products (RAGE) SOLUTION STRUCTURE OF C-TERMINAL RAGE (ctRAGE) AND ITS BINDING TO mDia1
Vivek Rai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
NADPH Oxidase 4 Mediates Insulin-Stimulated HIF-1α and VEGF Expression, and Angiogenesis In Vitro
Dan Meng et al.
PLOS ONE (2012)
Role of Advanced Glycation End Products (AGEs) in Osteoporosis in Diabetes
Sho-ichi Yamagishi
CURRENT DRUG TARGETS (2011)
Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures A meta-analysis of randomized clinical trials
Matteo Monami et al.
DIABETES CARE (2011)
Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes
M. C. Bunck et al.
DIABETES OBESITY & METABOLISM (2011)
Differential Effects of PPAR-γ Activation versus Chemical or Genetic Reduction of DPP-4 Activity on Bone Quality in Mice
Kimberly A. Kyle et al.
ENDOCRINOLOGY (2011)
GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia
Bernardo Nuche-Berenguer et al.
JOURNAL OF ENDOCRINOLOGY (2011)
Fifteen formins for an actin filament: A molecular view on the regulation of human formins
Andre Schoenichen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose
Gerlies Bock et al.
CLINICAL ENDOCRINOLOGY (2010)
Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia
Yasuyuki Katayama et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States
Bernardo Nuche-Berenguer et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
Barry I. Hudson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Regulation of osteoblast differentiation by transcription factors
Toshihisa Komori
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes
Gary A. Herman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Regulation of osteoclast function and bone mass by RAGE
Z Zhou et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy
S Yamagishi et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase
T Ago et al.
CIRCULATION (2004)
Diabetes and advanced glycation endproducts
H Vlassara et al.
JOURNAL OF INTERNAL MEDICINE (2002)
Bone mineral changes in obese women during a moderate weight loss with and without calcium supplementation
LB Jensen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Share Paper
